Nutritional Status and Dietary Intakes of The Patients With Mild-To-Moderate Alzheimer's Disease

被引：0
|
作者：
Fernando, Malika [1 ]
Marliya, Thasmeeha [2 ]
Raeesa, Fathima [2 ]
Williams, Shehan [1 ]
Silva, Renuka [2 ]
机构：
[1] Univ Kelaniya, Fac Med, Dept Psychiat, Colombo, Sri Lanka
[2] Wayamba Univ Sri Lanka, Fac Livestock Fisheries & Nutr, Dept Appl Nutr, Kuliyapitiya, Sri Lanka
来源：
ANNALS OF NUTRITION AND METABOLISM | 2019年 / 75卷
关键词：
Alzheimer's Disease; Nutritional status; Dietary intakes; Micronutrients;
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
828
引用
收藏
页码：294 / 294
页数：1
相关论文
共 50 条
  • [21] Dose Effects Associated with Rivastigmine Transdermal Patch in Patients with Mild-to-Moderate Alzheimer's Disease
    Grossberg, George T.
    Somogyi, Monique
    Meng, Xiangyi
    AMERICAN JOURNAL OF GERIATRIC PSYCHIATRY, 2011, 19 (03): : S121 - S122
  • [22] Systolic blood pressure variability and subcortical hyperintensities in patients with mild-to-moderate Alzheimer's disease
    Correia, S
    Salloway, S
    Malloy, P
    Song, C
    Li, R
    NEUROBIOLOGY OF AGING, 2004, 25 : S278 - S279
  • [23] Dose effects associated with rivastigmine transdermal patch in patients with mild-to-moderate Alzheimer's disease
    Grossberg, G. T.
    Olin, J. T.
    Somogyi, M.
    Meng, X.
    INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 2011, 65 (04) : 465 - 471
  • [24] Efficacy of rosiglitazone in a genetically defined population with mild-to-moderate Alzheimer's disease
    M E Risner
    A M Saunders
    J F B Altman
    G C Ormandy
    S Craft
    I M Foley
    M E Zvartau-Hind
    D A Hosford
    A D Roses
    The Pharmacogenomics Journal, 2006, 6 : 246 - 254
  • [25] Nicergoline in the treatment of mild-to-moderate Alzheimer's disease - A European multicentre trial
    Winblad, B
    Bonura, ML
    Rossini, BM
    Battaglia, A
    CLINICAL DRUG INVESTIGATION, 2001, 21 (09) : 621 - 632
  • [26] Estimating attrition in mild-to-moderate Alzheimer's disease and mild cognitive impairment clinical trials
    Ritchie, Marina
    Gillen, Daniel L.
    Grill, Joshua D.
    ALZHEIMERS RESEARCH & THERAPY, 2023, 15 (01)
  • [27] Two Phase 3 Trials of Bapineuzumab in Mild-to-Moderate Alzheimer's Disease
    Salloway, Stephen
    Sperling, Reisa
    Fox, Nick C.
    Blennow, Kaj
    Klunk, William
    Raskind, Murray
    Sabbagh, Marwan
    Honig, Lawrence S.
    Porsteinsson, Anton P.
    Ferris, Steven
    Reichert, Marcel
    Ketter, Nzeera
    Nejadnik, Bijan
    Guenzler, Volkmar
    Miloslavsky, Maja
    Wang, Daniel
    Lu, Yuan
    Lull, Julia
    Tudor, Iulia Cristina
    Liu, Enchi
    Grundman, Michael
    Yuen, Eric
    Black, Ronald
    Brashear, H. Robert
    NEW ENGLAND JOURNAL OF MEDICINE, 2014, 370 (04): : 322 - 333
  • [28] Efficacy of rosiglitazone in a genetically defined population with mild-to-moderate Alzheimer's disease
    Risner, M. E.
    Saunders, A. M.
    Altman, J. F. B.
    Ormandy, G. C.
    Craft, S.
    Foley, I. M.
    Zvartau-Hind, M. E.
    Hosford, D. A.
    Roses, A. D.
    PHARMACOGENOMICS JOURNAL, 2006, 6 (04): : 246 - 254
  • [29] Effects of Oral Rivastigmine on Cognitive Domains in Mild-to-Moderate Alzheimer's Disease
    Farlow, Martin R.
    Cummings, Jeffrey L.
    Olin, Jason T.
    Meng, Xiangyi
    AMERICAN JOURNAL OF ALZHEIMERS DISEASE AND OTHER DEMENTIAS, 2010, 25 (04): : 347 - 352
  • [30] Obstructive sleep apnoea and cognitive decline in mild-to-moderate Alzheimer's disease
    Jorge, Carmen
    Targa, Adriano
    Benitez, Ivan David
    Dakterzada, Faride
    Torres, Gerard
    Minguez, Olga
    Carnes, Anna
    Pujol, Montse
    Gibert, Aurora
    Lopez, Ricard
    Gaeta, Anna Michela
    Dalmases, Mireia
    Farre, Ramon
    Sanchez-de-la-Torre, Manuel
    Barbe, Ferran
    Pinol-Ripoll, Gerard
    EUROPEAN RESPIRATORY JOURNAL, 2020, 56 (05)
12345